PDCD1 and melanoma: Nevertheless, two patients in our study demonstrated an immediate and parallel decrease of IL-6 and S100B serum levels after administration of checkpoint inhibitor treatment which might result from a direct suppressive effect of PD-1 blockade on melanoma cell cycle.